Literature DB >> 27505855

Puerarin inhibits the inflammatory response in atherosclerosis via modulation of the NF-κB pathway in a rabbit model.

Ling Ji1, Qiang Du2, YunTao Li3, Wenzhi Hu4.   

Abstract

BACKGROUND: The isoflavone puerarin [7-hydroxy-3-(4-hydroxyphenyl)-1-benzopyran-4-one 8-(β-D-glucopyranoside)] possesses many biological activities. In this study, we investigated the effects of puerarin on adhesion molecules (AMs), including serum levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial leukocyte adhesion molecule-1 (E-selectin), and the activation of nuclear factor kappa B (NF-κB) in rabbits with experimental atherosclerosis.
METHODS: In total, 24 rabbits were divided into control (standard diet), high-lipid diet (HLD), and PUE (HLD supplemented with puerarin) groups. At the end of weeks 0, 8, and 16, serum levels of AMs were measured. At the end of week 16, the thickness of the intima was detected. Protein and mRNA levels of AMs were checked by immunohistochemistry and RT-PCR, respectively. Protein levels of p65 NF-κB and phosphorylation of inhibitor-κB (I-κB) were investigated by Western blotting.
RESULTS: Atherosclerotic lesions in the thoracic arch were found in the HLD and PUE groups, but not in the control group. Compared with the HLD group, the thickness of the intima in the PUE group was reduced. Our results indicate that puerarin reduced the protein and mRNA levels of AMs in this rabbit model. We also found that the reduced AM levels were due to inhibition of the phosphorylation and degradation of I-κB, resulting in reduced p65 NF-κB nuclear translocation.
CONCLUSIONS: This study indicates that the effect of puerarin on the suppression of atherosclerosis was connected with an inhibited inflammatory response and reduced NF-κB activation. Crown
Copyright © 2016. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Adhesion molecules; Atherosclerosis; Nuclear factor-κB; Puerarin; Rabbit

Mesh:

Substances:

Year:  2016        PMID: 27505855     DOI: 10.1016/j.pharep.2016.06.007

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  11 in total

1.  Puerarin Attenuates LPS-Induced Inflammatory Responses and Oxidative Stress Injury in Human Umbilical Vein Endothelial Cells through Mitochondrial Quality Control.

Authors:  Xing Chang; Tian Zhang; Dong Liu; Qingyan Meng; Peizheng Yan; Duosheng Luo; Xue Wang; XiuTeng Zhou
Journal:  Oxid Med Cell Longev       Date:  2021-02-27       Impact factor: 6.543

Review 2.  An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge.

Authors:  Doha H Abou Baker
Journal:  Toxicol Rep       Date:  2022-03-14

3.  A Novel Microspheres Formulation of Puerarin: Pharmacokinetics Study and In Vivo Pharmacodynamics Evaluations.

Authors:  Xiao Song; Xihui Bai; Shiyu Liu; Linjuan Dong; Hui Deng; Changli Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-29       Impact factor: 2.629

4.  Puerarin Alleviates Depression-Like Behavior Induced by High-Fat Diet Combined With Chronic Unpredictable Mild Stress via Repairing TLR4-Induced Inflammatory Damages and Phospholipid Metabolism Disorders.

Authors:  Li-Na Gao; Maocai Yan; Lirun Zhou; Jian'an Wang; Chunmei Sai; Yingjie Fu; Yang Liu; Lin Ding
Journal:  Front Pharmacol       Date:  2021-12-15       Impact factor: 5.810

Review 5.  Effects of puerarin on chronic inflammation: Focus on the heart, brain, and arteries.

Authors:  Li Zhang; Lisheng Liu; Mingyi Wang
Journal:  Aging Med (Milton)       Date:  2021-12-15

Review 6.  Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review.

Authors:  Shuangqiu Wang; Jiarui Ma; Yanqi Zeng; Guowei Zhou; Yuxuan Wang; Wenjuan Zhou; Xiaohe Sun; Minghua Wu
Journal:  Drug Des Devel Ther       Date:  2021-08-20       Impact factor: 4.162

7.  Puerarin inhibits vascular smooth muscle cells proliferation induced by fine particulate matter via suppressing of the p38 MAPK signaling pathway.

Authors:  Qiang Wan; Zhongyong Liu; Yuping Yang
Journal:  BMC Complement Altern Med       Date:  2018-05-04       Impact factor: 3.659

8.  Puerarin Attenuates Obesity-Induced Inflammation and Dyslipidemia by Regulating Macrophages and TNF-Alpha in Obese Mice.

Authors:  Ji-Won Noh; Hee-Kwon Yang; Min-Soo Jun; Byung-Cheol Lee
Journal:  Biomedicines       Date:  2022-01-14

Review 9.  Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases.

Authors:  Yan-Xi Zhou; Hong Zhang; Cheng Peng
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

Review 10.  Study on the Correlation Between NF-κB and Central Fatigue.

Authors:  Xingzhe Yang; Feng Li; Yan Liu; Danxi Li; Jie Li
Journal:  J Mol Neurosci       Date:  2021-02-14       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.